Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Discard the vial and reconstitute a new one
Garner mentioned that, Its primarily marketed for obesity management rather than weight loss. [3] In December 2024, the FDA approved Zepbound (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity
Further, while studies show several favourable effects, individual responses can still vary, and these outcomes are not guaranteed for every person
Some research suggests that GLP-1 medications may indirectly influence the gut microbiota through changes in dietary intake, gastric pH, and intestinal transit time, though studies specifically examining sex-based differences in this context are limited
